IM VETERINARIA #18

54 im veterinaria Referencias 1. Alexander GE, Chen K, Pietrini P, et al. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: APotential Outcome Mea- sure in Alzheimer’s Disease Treatment Studies. Am J Psychiatry 2002; 159: 738-745. 2. Araujo JA, Faubert ML, Brooks ML et al. Novifit (NoviSAMe) tablets improve executive function in aged dogs and cats: implications for treat- ment of cognitive dysfunction syndrome. Int J Appl Res Vet Med 2012; 10:91-8 3. Araujo J, Landsberg GM, Milgram NW et al. Improvement of short term memory performance in aged beagles by a nutraceutical supplement containing phosphatidylserine, Ginkgo biloba, vitamin E and pyroxidine. Can Vet J 2008; 49: 379-85 4. Araujo JA, Studzinski CM, Head E et al. Assessment of nutritional interventions for modification of age-associated cognitive decline using a canine model of human aging. AGE. 2005; 27: 27-37. 5. Castellano CA, Paquet N, Dionne IJ et al. A 3-month aerobic training program improve brain energy metabolism in mild Alzheimer’s disease: Preliminary results from a neuroimaging study. J Alz Dis 2017; 56:1459- 1468. 6. Cole GM, Ma QL, Frautschy SA. Omega-3 fatty acids and dementia. Prostaglandins, Leukotrienes and Essential Fatty Acids 2009; 81: 213- 221.7. 7. De Jager CA, Oulhaj A, Jacoby R et al. Cognitive and clinical outcome of homocysteine-lowering B-vitamin treatment in mild cognitive impair- ment: a randomized controlled trial. Int J Geriatr. Psychiatry. 2011; 27: 592-600. 8. Dong JY, Qin LQ, Zhang Z et al. Effect of oral L-arginine supplemen- tation on blood pressure: a meta-analysis of randomized, doubleblind, placebo-controlled trials. Am Heart J 2011; 162: 959-965 9. Drzezga A, Lautenschlager N, Siebner H, et al. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer’s disease: a PET follow-up study. Eur J Nucl Med Mol Imag- ing 2003; 30:1104-1113. 10. Duron E, Hanon O Hypertension, cognitive decline and dementia. Arch Cardiovasc Dis 2008; 101, 181–189. 11. Fast, R, Schutt T, Toft N et al. An observational study with long-term follow-Up of canine cognitive dysfunction: clinical characteristics, surviv- al, and risk factors. J Vet Int Med 2013; 27:822-829 12. Feart C, Samieri C & Barberger-Gateau P (2010) Mediterranean diet and cognitive function in older adults. Curr Opin Clin Nutr Metab Care 13, 14–18. 13. Frank B, Gupta S (2005) A review of antioxidants and Alzheimer’s disease. Ann Clin Psychiatry 17, 269-286. 14. Head E, Murphey HL, Dowling AL, et al. A combination cocktail improves spatial attention in a canine model of human aging and Alzhei- mer’s disease. J Alz Dis 2012; 32:1029–1042. 15. Head E, Nukala VN, Fenoglio KA et al. Effects of age, dietary, and behavioral enrichment on brain mitochondria in a canine model of human aging. Experimental neurology. 2009; 220, 171-176 16. Head E, Liu J, Hagen TM, et al: Oxidative damage increases with age in a canine model of human brain aging. J Neurochem 82:375-81, 2002. 17. Heath SE, Barabas S, Craze PG. Nutritional supplementation in cases of canine cognitive dysfunction - a clinical trial. Appl Anim Behav Sci 2007; 105: 274-83 18 Henderson S. Ketone bodies as a therapeutic for Alzheimers disease. Neurotherapeutics 2008; 5, 470-80 19. Katina S, Farbikova J, Madari A, et al. Risk factors for canine cogni- tive dysfunction syndrome in Slovakia. Acta Vet Scand 2016; 58: 17 doi: http://dx.doi.org/10.1186%2Fs13028-016-0196-5 20. London ED, Ohata M, Takei H, et al. Regional cerebral metabolic rate for glucose in beagle dogs of different ages. Neurobiol Aging 1983; 4: 121–126 21. Madari A, Farbakova J, Katina S et al. (2015) Assessment of severity and progression of canine cognitive dysfunction syndrome using the Ca- nine Dementia Scale (CADES). Appl Anim Behav Sci 17: 138-145 22. Milgram NW et al. Long term treatment with antioxidants and a pro- gram of behavioural enrichment reduces age-dependant impairment in discrimination and reversal learning in beagle dogs. Exp Gerentol 2004; 39: 753-765 23. Milgram NW, Landsberg GM, Merrick D et al. ANovel Mechanism for Cognitive Enhancement in Aged Dogs with the use of a Calcium Buff- ering Protein. J Vet Behav 2015; 10: 217-222 24. Miller JW, Green R, Ramos MI et al. Homocysteine and cognitive function in the Sacramento Area, Latino Study on Aging. Am J Clin Nutr 2003; 78: 441-47 25. Neilson JC, Hart BL, Cliff KD, et al. Prevalence of behavioral changes associated with age-related cognitive impairments in dogs. J Am Vet Med Assoc 2001; 18: 1987-91. 26. Osella, MC, Re G, Odore R, et al. Canine cognitive dysfunction syn- drome: prevalence, clinical signs and treatment with a neuroprotective nutraceutical. Appl Anim Behav Sci 2007; 105: 297-310 27. Oulhaj A, Jernerén F, Refsum H, et al. Omega-3 fatty acid status en- hances the prevention of cognitive decline by B vitamins in mild cognitive impairment. J Alz Dis 2016; 50: 547-57 28. Pan Y, Larson B, Araujo JA et al. Dietary supplementation with medi- um-chain TAG has long-lasting cognition-enhancing effects in aged dogs. Br J Nutr 2010; 103: 1746-54 29. Pan Y, Araujo JA, Burrows J, et al. Cognitive enhancement in mid- dle-aged and old cats with dietary supplementation with a nutrient blend containing fish oil, B vitamins, antioxidants and arginine. British J Nutr 2012; 10, 1-10 30. Pan Y, Landsberg G, Mougeot I et al. Efficacy of a therapeutic diet on dogs with clinical signs of cognitive dysfunction syndrome (CDS); a double blinded placebo controlled study. Proc ACVIM, Washington D.C., 2017 31. Pan Y, Kennedy AD, Jönsson TJ et al. Cognitive enhancement in old dogs from dietary supplementation with a nutrient blend contain- ing arginine, antioxidants, B vitamins and fish oil, Br J Nutr 2018 doi. org/10.1017/S0007114517003464 32. Reger MA, ST, Hale C, et al. Effects of beta-hydroxybutyrate on cog- nition in memory-impaired adults. Neurobiol Aging 2004; 25: 311-314 33. Rème CA, Dramard V, Kern L et al. Effect of S-adenosylmethionine tablets on the reduction of age-related mental decline in dogs: a dou- ble-blind placebo-controlled trial. Vet Ther 2008; 9: 69-82 34. Rosado B, Gonzalez-Martinez P, Pesini P et al. Effect of age and se- verity of cognitive dysfunction on spontaneous activity in pet dogs- Part I. Locomotor and exploratory behaviour. Vet J 2012; 194: 189-95. 35. Salvin HE, McGreevy PD, Sachdev PS et al. The canine cognitive dysfunction rating scale (CCDR): a data-driven and ecologically relevant assessment tool. Vet J 2011; 188: 331-336 36. Salvin HE et al. Under diagnosis of canine cognitive dysfunction; a cross-sectional survey of older companion dogs. Vet J 2010; 184, 277-81 37. Selhub J, Bagley LC, Miller J, et al. B vitamins, homocysteine, and neurocognitive function in the elderly. Am J Clin Nutr 2000; 71: 614S–620S 38. Siwak CT, Tapp PD, Zicker SC, et al. Locomotor activity rhythms in dogs vary with age and cognitive status. Behav Neurosci 2003; 117: 813- 24 39. Siwak CT, Tapp PD, Milgram NWEffect of age and level of cognitive function on spontaneous and exploratory behaviours in the Beagle dog. Learn Mem 2001; 8: 65-70. 40. Snigdha S, de Rivera C, Milgram NW et al. Exercise enhances memo- ry consolidation in the aging brain. Front Aging Neurosci. 2014 Feb 3;6:3. doi: 10.3389/fnagi.2014.00003 41. Studzinski CM, Christie LA, Araujo JA et al. Visuospatial function in the beagle dog: an early marker of cognitive decline in a model of human aging and dementia. Neurobiol Learn Mem 2006; 86: 197-204 42. Taha AY, Henderson ST, BurnhamWM. Dietary enrichment with me- dium chain-triglycerides (AC-1203) elevates polyunsaturated fatty acids in the parietal cortex of aged dogs; implications for treating age-related cognitive decline. Neurochem Res 2009; 34: 1619-25 43. Taupin P. A dual activity of ROS and oxidative stress on adult neuro- genesis and Alzheimer’s disease. Central Nervous SystemAgents in Me- dicinal Chemistry 2010; 10: 16–21. 44. Vandenberghe C, Castellano CA, Maltais M et al. A short-term in- tervention combining aerobic exercise with medium-chain triglyceride (MCT) is more ketogenic than either MCT or aerobic exercise alone: A comparison of normoglycemic and pre-diabetic older women. Appl Physi- ol Nutr Metab. 2018 doi: 10.1139/apnm-2018-0367. [Epub ahead of print] 45. Weninger SC, Yankner BA. Inflammation and Alzheimer disease: the good, the bad, and the ugl y. Nature Medicine 2001; 7: 527–28. 46. Yurko-Mauro K. Cognitive and cardiovascular benefits of doco- sahexaenoic acid in aging and cognitive decline. Curr Alzheimer Res. 2010;7:190-6. 47. Zanghi BM, Araujo JA, Milgram NW. Cognitive domains in the dog: independence of working memory from object learning, selective attention and motor learning. Anim Cogn 2015; 18: 789-800